Table: Aska Pharmaceutical - 9-MTH group results

ASKA Pharmaceutical Holdings

01/02/2021 06:00

Feb 1 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             43.35               41.21            54.00    
                 (+5.2 pct)          (+11.3 pct)      (+2.8 pct)  
  Operating          3.78                1.52             2.80    
                (+148.4 pct)         (-41.0 pct)      (+85.8 pct) 
  Recurring          3.23                1.73             2.10    
                 (+86.4 pct)         (-38.2 pct)      (+22.4 pct) 
  Net                2.45                1.06             1.90    
                (+130.2 pct)         (-52.0 pct)     (+192.5 pct) 
  EPS             86.47 yen           37.66 yen        67.02 yen  
  Ann Div                             17.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             10.00 yen        7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T